Apath is a privately held technology licensing company engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. The current focus of Apath is on hepatitis C virus (HCV). The company also works with other RNA viruses that are human pathogens, including Influenza, Respiratory Syncytial Virus (RSV) and Hemorrhagic Fever Viruses.